{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:38:16Z","timestamp":1790264296969,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/gme.0b013e3181f43404","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T05:15:30Z","timestamp":1291266930000},"page":"385-392","source":"Crossref","is-referenced-by-count":87,"title":["Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009"],"prefix":"10.1097","volume":"18","author":[{"given":"Sandra A.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia L.","family":"Stefanick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall S.","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R2-9-20210211","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence.","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"key":"R4-9-20210211","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjmed.2005.09.059","article-title":"Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.","volume":"118","author":"Stefanick","year":"2005","journal-title":"Am J Med"},{"key":"R5-9-20210211","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"R6-9-20210211","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch Intern Med"},{"key":"R7-9-20210211","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"R8-9-20210211","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/gme.0b013e3181d0f6b9","article-title":"Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.","volume":"17","year":"2010","journal-title":"Menopause"},{"key":"R10-9-20210211","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13697130701361657","article-title":"IMS updated recommendations on postmenopausal hormone therapy.","volume":"10","author":"Pines","year":"2007","journal-title":"Climacteric"},{"key":"R11-9-20210211","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1258\/MI.2007.007037","article-title":"Primary prevention of coronary heart disease in women.","volume":"14","author":"Rees","year":"2008","journal-title":"Menopause Int"},{"key":"R12-9-20210211","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/aje\/kwp115","article-title":"Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.","volume":"170","author":"Prentice","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R13-9-20210211","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial.","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"R14-9-20210211","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","article-title":"The decrease in breast-cancer incidence in 2003 in the United States.","volume":"356","author":"Ravdin","year":"2007","journal-title":"N Engl J Med"},{"key":"R15-9-20210211","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ije\/dyn055","article-title":"Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections.","volume":"37","author":"Krieger","year":"2008","journal-title":"Int J Epidemiol"},{"key":"R16-9-20210211","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1200\/JCO.2006.08.6504","article-title":"Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.","volume":"24","author":"Clarke","year":"2006","journal-title":"J Clin Oncol"},{"key":"R17-9-20210211","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"R21-9-20210211","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(02)02670-0","article-title":"The underutilization of cardiac medications of proven benefit, 1990 to 2002.","volume":"41","author":"Stafford","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R23-9-20210211","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/01.AOG.0000143826.38439.af","article-title":"Hormone therapy prescribing patterns in the United States.","volume":"104","author":"Buist","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R24-9-20210211","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.AOG.0000220502.77153.5a","article-title":"Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.","volume":"108","author":"Hing","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R25-9-20210211","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-140-3-200402030-00009","article-title":"Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results.","volume":"140","author":"Haas","year":"2004","journal-title":"Ann Intern Med"},{"key":"R26-9-20210211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6874-7-19","article-title":"Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.","volume":"7","author":"Du","year":"2007","journal-title":"BMC Womens Health"},{"key":"R27-9-20210211","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.gme.0000172595.68648.16","article-title":"Recent reversal of trends in hormone therapy use in a European population.","volume":"13","author":"Morabia","year":"2006","journal-title":"Menopause"},{"key":"R28-9-20210211","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women.","volume":"360","author":"Chlebowski","year":"2009","journal-title":"N Engl J Med"},{"key":"R29-9-20210211","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.","volume":"15","author":"Grodstein","year":"2006","journal-title":"J Womens Health"},{"key":"R30-9-20210211","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.gme.0000177906.94515.ff","article-title":"Postmenopausal hormone therapy: new questions and the case for new clinical trials.","volume":"13","author":"Manson","year":"2006","journal-title":"Menopause"},{"key":"R32-9-20210211","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/gme.0b013e31803167ab","article-title":"Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R33-9-20210211","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.0000115383.49802.0c","article-title":"Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.","volume":"24","author":"Wakatsuki","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R34-9-20210211","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.maturitas.2006.08.004","article-title":"Benefits and risks of long-term low-dose oral continuous combined hormone therapy.","volume":"56","author":"van de Weijer","year":"2007","journal-title":"Maturitas"},{"key":"R35-9-20210211","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"key":"R36-9-20210211","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.maturitas.2006.02.002","article-title":"Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys.","volume":"55","author":"Appt","year":"2006","journal-title":"Maturitas"},{"key":"R37-9-20210211","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2007.02.025","article-title":"Rationale for use of lower estrogen doses for postmenopausal hormone therapy.","volume":"57","author":"Ettinger","year":"2007","journal-title":"Maturitas"},{"key":"R38-9-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2005.05.003","article-title":"New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.","volume":"52","author":"Modena","year":"2005","journal-title":"Maturitas"},{"key":"R39-9-20210211","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.AOG.0000284450.51264.31","article-title":"Lowest effective transdermal 17-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.","volume":"110","author":"Bachmann","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R40-9-20210211","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/13697130902748967","article-title":"Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.","volume":"12","author":"Haines","year":"2009","journal-title":"Climacteric"},{"key":"R41-9-20210211","doi-asserted-by":"crossref","first-page":"909s","DOI":"10.1158\/1078-0432.909s.11.2","article-title":"Estrogen, estrogen plus progestin therapy, and risk of breast cancer.","volume":"11","author":"Colditz","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R42-9-20210211","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amjmed.2005.09.035","article-title":"Vasomotor symptom relief versus unwanted effects: role of estrogen dosage.","volume":"118","author":"Ettinger","year":"2005","journal-title":"Am J Med"},{"key":"R43-9-20210211","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-201104000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:49:36Z","timestamp":1786042176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-201104000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181f43404","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}